Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New section on PTSC's website

2 Billion plus market in "Integrated Inter-Agency Secure Information Solution"

5 Million plus market in "Integrated Healthcare Information Solution".



That's over a $7 Billion market PTSC is going after. Suppose they land just one percent of that market. That would be $70 Million per year. If they expect that to be 2/3 of the revenue, that would still leave $35M per year in MMP for a total annual revenue of $105M. Not too shabby. If they can pull that off at about 30% margin, that would leave PTSC with about $32M in net revenue, and $21M after tax profit. That could be clear consistent predictable revenue.

Apply an industry average PE ratio of 19 to that using the likely 420M shares we'll have out after the Crossflo deal, and you get to 95 cents per share.



Now... what if PTSC can get 2% of the market...5%? A ways away...perhaps but interesting to me at least..... I hope once the Crossflo deal is complete and integrated, RG can begin to expound a bit more on this vision and the potentials of it.

Share
New Message
Please login to post a reply